Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
09/2005
09/08/2005US20050197383 Quaternary ammonium compounds and their use as anti-tussive agents
09/08/2005US20050197363 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
09/08/2005US20050197362 Preventives/remedies for urinary disturbance
09/08/2005US20050197346 Substituted heterocyclic compounds
09/08/2005US20050197326 1,4-benzothiazin-3-ones that are optionally S-mono- or dioxygenated, quinoxazinones, quinolinones and benzapinones; peptide deformylase inhibitors, used for treating bacterial infections
09/08/2005US20050196556 Ink jet recording material
09/08/2005US20050196555 Ink jet recording material
09/08/2005US20050196554 Ink-receiving layer with light-fastness and photostability
09/08/2005DE19629238B4 Basische Azoverbindungen, deren Herstellung und Verwendung Basic azo compounds, their preparation and use
09/07/2005EP1571150A1 Process for the preparation of tryptase inhibitors
09/07/2005EP1569934A2 Cyclopropyl compounds as ccr5 antagonists
09/07/2005EP1569905A2 Inhibitors of monoamine uptake
09/07/2005EP1569896A1 Tetrahydro-naphthalene derivatives
09/07/2005EP1569647A2 Cyclohexyl compounds as ccr5 antagonists
09/07/2005EP1492767B1 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa
09/07/2005EP1438291B1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
09/07/2005EP1289953B1 Serine protease inhibitors
09/07/2005EP1192132B1 Serine protease inhibitors
09/07/2005CN1665801A Anti tubercular drug: compositions and methods
09/07/2005CN1665786A Secondary amino anilinic piperidines as MCH1 antagonists and uses thereof
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1665501A Novel compounds as opioid receptor modulators
09/07/2005CN1217932C Antibacterial agents
09/07/2005CN1217920C Compounds to treat Alzheimer disease
09/06/2005US6939883 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
09/06/2005US6939875 Carbocyclic oxy sulfides such as [4-(Biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid, used to control peroxisome proliferator activated receptors (PPAR), for prophylaxis of metabolic disorders
09/06/2005CA2275592C Method for preparing a tetrahydropyridin derivative
09/01/2005WO2005080976A1 Method of in vivo screening of therapeutic agent for memory/learning dysfunction by schizophrenia
09/01/2005WO2005080527A1 Anthracene derivative host having ranges of dopants
09/01/2005WO2005080394A1 4-substituted piperidine derivatives
09/01/2005WO2005080372A1 Dihydropyridinone derivatives
09/01/2005WO2005080339A1 Sulfonyloxy derivatives
09/01/2005WO2005080322A1 Fluorene derivative
09/01/2005WO2005080318A1 PROCESSES FOR PRODUCTION OF α-AMINOOXYKETONES AND α-HYDROXYKETONES
09/01/2005WO2005079863A1 Contrast medium for thrombus formation
09/01/2005WO2005070133A3 2,6-disubstituted piperidines as modulators of chemokine receptor activity
09/01/2005WO2005037772A3 Novel ligand activating receptors rars used for human medicine and cosmetics
09/01/2005WO2005021523A8 Piperazine substituted compounds used as calcium channel blockers
09/01/2005US20050192323 Novel crude and crystalline forms of lercanidipine hydrochloride
09/01/2005US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder
09/01/2005US20050192291 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
09/01/2005US20050192283 Fused-aryl and heteroaryl derivatives and methods of their use
09/01/2005US20050189873 Liquid crystalline emitter and charge-transport materials for use in organic light emitting devices (OLED); photopolymerization; high luminous output; tetra-enes based on a fluorene ring skeleton and having at least one heterocyclic ring attached
09/01/2005CA2558064A1 Contrast medium for thrombus formation
09/01/2005CA2557537A1 Sulfonyloxy derivatives
09/01/2005CA2556589A1 4-substituted piperidine derivatives
09/01/2005CA2537079A1 Fluorene derivative
08/2005
08/31/2005EP1568702A1 Palladium complexes with heterocyclic ligands
08/31/2005EP1568691A1 Erythropoietin production accelerator
08/31/2005EP1568690A1 The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers
08/31/2005EP1568688A1 Therapeutic agent for respiratory disease containing 4-hydroxypiperidine derivative as active ingredient
08/31/2005EP1568686A1 n-alkylaminated secondary paraphenylendiamine, which is ortho- and/or meta-substituted, dying composition comprising this paraphenylendiamine, methods based on this composition and uses
08/31/2005EP1568683A2 Secondary, N-alkylaminated para-phenylenediamines, compositions for dyeing keratinic fibres containing them, processes using this compositions and uses thereof
08/31/2005EP1568355A1 N-alkylhydroxilated secondary paraphenylenediamine which is ortho- and/or meta substituted, composition for dying keratinous fibres comprising this paraphenylenediamine, methods based on this composition and uses.
08/31/2005EP1567511A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
08/31/2005EP1567498A2 Mandelic acid derivatives
08/31/2005EP1567496A1 Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders
08/31/2005EP1567495A2 Small technetium-99m and rhenium labeled agents and methods for imaging tissues, organs and tumors
08/31/2005EP1567494A1 Methods for preparing phenylalkyne derivatives
08/31/2005EP1567493A1 Phenyl substituted piperidine compounds for use as ppar activators
08/31/2005EP1567488A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease
08/31/2005EP1567487A2 Open chain prolyl urea-related modulators of androgen receptor function
08/31/2005EP1395576B1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
08/31/2005CN1662535A Spiroindolinepiperidine derivatives
08/31/2005CN1662521A Compounds useful for the treatment of obesity, type ii diabetes and cns disorders
08/31/2005CN1662504A 2, 5-disubstituted 3-mercaptopentanoic acid
08/31/2005CN1662501A Cyanoguanidine prodrugs
08/31/2005CN1662500A Novel azasugar derivative and drug containing the same as the active ingredient
08/31/2005CN1662499A Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays
08/31/2005CN1662498A Novel tetrahydropyridine derivatives as renin inhibitors
08/31/2005CN1662497A Derivative of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics
08/31/2005CN1662488A Method for making aryl hydrazines and substituted indoles
08/31/2005CN1662487A Amide linker peroxisome proliferator activated receptor modulators
08/31/2005CN1660839A Chemical compounds
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
08/31/2005CN1660809A Method for preparing 3-methylamino piperidine and its salt
08/31/2005CN1660808A Method for continuous extracting chlorophyll and isoflavone from haulm of liquorice and application
08/30/2005US6936670 polymerizing an ethylenically unsaturated monomer with multifunctional alkoxyamine as living polymerization initiator
08/30/2005US6936669 copolymerizing at least one conjugated diolefin monomer and at least one functionalized monomer in an organic solvent, initiated with an anionic initiator, wherein the polymerization is conducted in the presence of an alkali alkoxide
08/30/2005US6936625 Amlodipine camsylate and method for preparing thereof
08/30/2005US6936621 Use of benzoylalkyl-1,2,3,6-tetrahydropyridines
08/30/2005US6936614 Piperidine-piperazine ligands for neurotransmitter receptors
08/30/2005US6936611 Serine protease inhibitors
08/30/2005US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases
08/30/2005US6936077 1,3-diamino-4-(aminomethyl)—benzene derivatives and colorants containing the said compounds
08/30/2005CA2137747C Process for the continuous preparation of 2,2,6,6-tetramethylpiperidine
08/25/2005WO2005077899A2 Amino-substituted tricyclic derivatives and methods of use
08/25/2005WO2005077898A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
08/25/2005WO2005077884A2 Hydroaminomethylation of olefins
08/25/2005WO2005077463A2 Ligand for a monoamine receptor or transporter for treating addiction or dependence
08/25/2005WO2005077369A1 Piperidine derivatives useful as ccr3 antagonists
08/25/2005WO2005076749A2 A novel process for the preparation of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine
08/25/2005WO2005011601A3 6-menbered heteroaryl compounds for the treatment of neurodegenerative disorders
08/25/2005US20050187297 New compounds, methods for their preparation and use thereof
08/25/2005US20050187261 For hepatitis C; histone deacetylase inhibitors, anticarcinogenic agents; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides; amidation of a benzoic acid, benzoate, benzoyl halide with hydroxyamine
08/25/2005US20050187252 Novel compounds as opioid receptor modulators
08/25/2005US20050187251 Substituted N-heterocycle derivatives and methods of their use
08/25/2005US20050187222 Therapy for impotency, erectile dysfuction; benign prostatic hyperplasia; hypotensive agents; congestive heart failure; vision defects; neurodegenerative disorders; incotinence; cognition activators
08/25/2005US20050187110 Novel herbicides
08/25/2005US20050186265 Negatively charged first lipid; barium, calcium, zinc, magnesium and/or cation; carbohydrates, vitamins, minerals, polynucleotides, polypeptides, lipids, flavors and drugs; particle sizes; storage stability, oxidation resistance, dimensional stability;
1 ... 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 ... 380